首都在線(300846.SZ):子公司中瑞雲祥獲得高新技術企業證書
格隆匯 2 月 4日丨首都在線(300846.SZ)公佈,近日,公司子公司北京中瑞雲祥信息科技發展有限公司(“中瑞雲祥”)收到由北京市科學技術委員會、北京市財政局、國家税務總局北京市税務局聯合頒發的《高新技術企業證書》。
中瑞雲祥為首次通過高新技術企業認定,根據國家對高新技術企業的相關税收優惠政策,中瑞雲祥自本次通過認定後,將連續三年享受國家關於高新技術企業的税收優惠政策,即2020年至2022年按15%的税率繳納企業所得税。
高新技術企業的認定是相關部門對公司子公司的創新研發能力、高新技術企業發展成果的充分肯定,有助於公司提高綜合競爭力,提升公司品牌形象,對公司未來的經營發展產生積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.